Phocas Financial Corp. Increases Position in Ralliant Corporation $RAL

Phocas Financial Corp. lifted its holdings in Ralliant Corporation (NYSE:RAL) by 81.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 157,116 shares of the company’s stock after purchasing an additional 70,403 shares during the period. Ralliant comprises about 1.0% of Phocas Financial Corp.’s portfolio, making the stock its 29th largest holding. Phocas Financial Corp.’s holdings in Ralliant were worth $7,999,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of RAL. Cetera Investment Advisers purchased a new position in shares of Ralliant in the 2nd quarter valued at about $700,000. Russell Investments Group Ltd. acquired a new stake in Ralliant in the 2nd quarter worth about $1,465,000. EverSource Wealth Advisors LLC acquired a new stake in Ralliant in the 2nd quarter worth about $39,000. First Trust Advisors LP acquired a new stake in Ralliant in the 2nd quarter worth about $2,013,000. Finally, Federated Hermes Inc. acquired a new stake in Ralliant in the 2nd quarter worth about $326,000.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Weiss Ratings cut Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday, February 5th. Morgan Stanley reiterated an “overweight” rating and issued a $45.00 price objective on shares of Ralliant in a report on Friday, February 6th. Citigroup lowered their price objective on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a report on Friday, February 6th. Zacks Research upgraded Ralliant from a “strong sell” rating to a “hold” rating in a report on Monday. Finally, Truist Financial lowered their target price on Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a report on Friday, February 6th. Seven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $50.50.

Ralliant Stock Down 0.4%

RAL stock opened at $46.54 on Wednesday. The firm has a market cap of $5.20 billion and a PE ratio of 23.74. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84. The firm’s 50 day moving average price is $43.69 and its 200-day moving average price is $46.76. Ralliant Corporation has a one year low of $37.27 and a one year high of $57.02.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. The firm had revenue of $554.60 million for the quarter, compared to analysts’ expectations of $543.04 million. The firm’s revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 23rd. Shareholders of record on Monday, March 9th were given a $0.05 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. Ralliant’s payout ratio is presently 10.20%.

Insider Buying and Selling

In other news, SVP Amir A. Kazmi bought 2,545 shares of the business’s stock in a transaction on Friday, February 6th. The shares were bought at an average price of $39.27 per share, with a total value of $99,942.15. Following the completion of the transaction, the senior vice president directly owned 39,699 shares in the company, valued at $1,558,979.73. This trade represents a 6.85% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kate Mitchell bought 2,350 shares of the business’s stock in a transaction on Tuesday, February 10th. The stock was purchased at an average cost of $42.48 per share, for a total transaction of $99,828.00. Following the transaction, the director owned 8,411 shares of the company’s stock, valued at $357,299.28. This trade represents a 38.77% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 8,145 shares of company stock valued at $332,233 over the last quarter.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.